1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with perflutren in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (perflutren) | Trials (perflutren) | Recent Studies (post-2010) (perflutren) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 1,177 | 90 | 467 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukuda, S; Greener, Y; Jablonski, E; Killam, AL; Schmid-Schönbein, GW; Suematsu, M; Tojo, SJ; Yasu, T | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and perflutren
Article | Year |
---|---|
Activated leukocytes and endothelial cells enhance retention of ultrasound contrast microspheres containing perfluoropropane in inflamed venules.
Topics: Animals; Blood Pressure; Endothelial Cells; Erythrocytes; Fluorocarbons; Heart Rate; Inflammation; Kinetics; Leukocytes; Male; Microcirculation; Microscopy, Fluorescence; Microspheres; Platelet Activating Factor; Rats; Rats, Wistar; Ultrasonography; Venules | 2005 |